Navigation Links
Statement from the Consumer Healthcare Products Association on Mississippi Bill that Limits Consumer Access to Cold and Allergy Medicines Containing Pseudoephedrine by Requiring a Prescription
Date:2/2/2010

WASHINGTON, Feb. 2 /PRNewswire-USNewswire/ -- The following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), in response to Senate passage of legislation which will require a prescription to access over-the-counter cold and allergy medicines containing pseudoephedrine:

"We are disappointed that the Mississippi Senate chose to overlook consumer sentiment and passed a bill today that will significantly impact how cold and allergy sufferers access some of their medicines. While well-intentioned, this bill will impose an unnecessary burden on Mississippians, despite there being a better and more effective solution to address the state's meth production problem.

"Under this legislation, if only half of those Mississippians who rely on these medicines are now forced to visit a doctor to obtain a prescription for these cold and allergy medicines containing pseudoephedrine, the cost to the healthcare system would be over $7 million. Additional impacts to the state include a loss of over half-a-million dollars from lost sales tax revenue, and notable cost increases to the state's Medicaid program and state employee and retiree programs. In a time of economic scrutiny, this option is counterproductive in addressing the current crisis in healthcare delivery—especially among Mississippi's uninsured and medically underserved.

"In the short time that this debate has been underway, Mississippians have spoken out that this is not the right way to address methamphetamine abuse. From comments on media stories to calls to the state legislature, many consumers have expressed outrage that the state is rushing to push this law through—especially when a more effective alternative is on the table. Electronic tracking of over-the-counter medicines containing pseudoephedrine serves as a more effective, less-costly alternative, and one that eight states have adopted to fight domestic methamphetamine production while maintaining consumer access to these medicines. An e-tracking system is a tool that law enforcement and pharmacists can use to stop the sale of illegal amounts of pseudoephedrine as set forth by the federal Combat Methamphetamine Epidemic Act of 2005. With this real-time tracking system, states can also link up with other states to track cross-border sales."

CHPA is the 129-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.

www.chpa-info.org

SOURCE Consumer Healthcare Products Association

RELATED LINKS
http://www.chpa-info.org

'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. AAPM statement on quality radiation therapy
2. Statement From American Heart Association CEO Nancy Brown on President Obamas State of the Union Address
3. Statement from the Consumer Healthcare Products Association on Mississippi Bill that Seeks to Make Cold, Allergy Medicines Containing Pseudoephedrine Prescription-Only
4. Statement from RC Cancer Centers Regarding News Story on Radiation Oncology
5. Statement From the American Health Care Association and National Center for Assisted Living in Anticipation of President Obamas State of the Union Address
6. SEIU-UHW Statement on Kaiser Union Election in Southern California
7. Operation Rescues Advisory Board Issues Statement on Mr. Terrys Extremism
8. Statement: Helping the UN Help Haiti
9. Pelosi Statement on New Report That Health Reform Will Create 4 Million More Jobs Over the Next Decade
10. Statement by Blue Shield of California CEO Bruce Bodaken Regarding the Groundbreaking for the Family Violence Prevention Funds International Center
11. Statement of US Secretary of Labor Hilda L. Solis on December 2009 employment numbers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... OAK BROOK, Ill. (PRWEB) , ... December 07, 2016 , ... ... linked to early-stage brain damage, according to a study appearing online in the journal ... the incidence is expected to increase significantly due to the rapidly aging population. Damage ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... AUSTIN, TX (PRWEB) , ... OCTOBER XX, 2016 ... ... may help solve another mystery. A new study entitled “Canine Filamentous Dermatitis ... Morgellons disease can occur in dogs. The study was published in the prestigious ...
(Date:12/7/2016)... ... 07, 2016 , ... Texas Premier Locksmith , a ... by unethical locksmith companies and is urging Search Engines to improve verification methods ... Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked out of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute ... the treatment modalities available in a single device. The announcement is part ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- Global Hospital Linen Supply and Management Services Market: ... supply and management services market presents a comprehensive analysis ... regional level. The study provides historic data of 2015 ... 2024 based on revenue (US$ Bn). The drivers and ... their impact on demand during the forecast period have ...
(Date:12/7/2016)... Dec. 7, 2016  Palatin Technologies, Inc. ("Palatin") ... on a previously disclosed underwritten public offering of ... acted as sole book-running manager, Roth Capital Partners ... acted as co-manager for the offering. ... in net proceeds, allowing us to continue advancing ...
(Date:12/7/2016)... 2016  Northwest Biotherapeutics (Nasdaq: NWBO ... company developing DCVax® personalized immune therapies for solid ... has not accepted the Company,s plan of remediation ... and the Company has notified Nasdaq of its ... from listing on Nasdaq.  Upon withdrawal from Nasdaq, ...
Breaking Medicine Technology: